Activating mutations in the epidermal growth factor receptor (EGFR) gene are found in roughly 10–15% of non-small cell lung cancer (NSCLC) cases among Caucasian patients and in up to 50% of Asian individuals [13,14]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.